IBB · iShares

iShares Biotechnology ETF

See how 246 reported holdings combine into this ETF’s P/E and P/S. Market value, signed ordinary earnings and revenue are added before each ratio is calculated.

Holdings dated 19 August 2026Price US$213.56 as of 21 August 2026Coverage limitations apply

Core valuation

Trailing P/E-152.67×93.09% coverage
Latest-quarter run-rate P/E-77.57×93.19% coverage
Trailing P/S7.57×81.39% coverage
Latest-quarter run-rate P/S7.56×81.44% coverage

Coverage is the share of positive eligible-equity holding value represented in each metric. The published holdings account for 100.00% of fund weight. The reliability standard requires at least 90.00% disclosed fund weight and metric coverage, with no individual uncovered holding above 1.00%.

Largest reported holdings

HoldingWeightTrailing P/ETrailing P/S
AMGNAMGEN INC8.40%30.40×6.37×
VRTXVERTEX PHARMACEUTICALS7.89%32.06×11.38×
GILDGILEAD SCIENCES INC7.02%19.69×6.10×
REGNREGENERON PHARMACEUTICALS5.81%20.31×6.02×
MRNAMODERNA INC4.34%-18.03×25.88×
ARGXARGENX SE ADR3.68%43.23×13.54×
NTRANATERA3.04%-210.11×19.01×
RVMDREVOLUTION MEDICINES2.80%-25.39×Unavailable
BIIBBIOGEN2.22%23.33×3.22×
ALNYALNYLAM PHARMACEUTICALS2.21%99.85×8.44×

Top 10 of 246 reported holdings. * A holding uses its latest full-year result only when both trailing and latest-quarter inputs are unavailable; open the stock for the exact year end.

Most similar funds

Ranked by shared weight across matching disclosed company holdings and explicitly reported same-currency cash.

  1. XBI · State Street SPDR S&P Biotech ETF41.42% holdings overlap · NYSE Arca
  2. FBT · First Trust NYSE Arca Biotechnology Index Fund35.95% holdings overlap · NYSE Arca
  3. BMED · iShares Health Innovation Active ETF34.38% holdings overlap · NYSE Arca
  4. IBBQ · Invesco Nasdaq Biotechnology ETF32.73% holdings overlap · US market
  5. PBE · Invesco Biotechnology & Genome ETF32.73% holdings overlap · US market

Sources and limitations

Holdings are sourced from iShares and company financial inputs retain primary-source links. Monetary values are normalised to USD. Corporate actions, reporting lags, unmapped securities and cash can create differences from provider figures.

Open official holdings source

Research holdings date: 19 August 2026. Informational research, not investment advice.

Wide tables can scroll horizontally.

ratio/fox calculates each ETF’s real P/E and P/S as if it was one single company.

ETFs

Loading ETF list
Page loading
ETFs with look-through P/E and P/S valuation and source details
ticker ETF P/E · trailing P/E · quarter P/S · trailing P/S · quarter issuer market listed on current price currency price in original currency price date price provider listing type relationship primary benchmark holdings forward P/E fwd P/E min fwd P/E max forward P/S fwd P/S min fwd P/S max earnings yield fwd earnings yield sales yield fwd sales yield trailing P/E value gap fwd P/E value coverage fwd P/E value gap trailing P/S value coverage trailing P/S value gap fwd P/S value coverage fwd P/S value gap coverage notes
Loading ETF list...